Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Taku Fujimura

Showing results (1-10 of 283) with videos related to

Pageof 29
Sort By:
Immunological Medicine|August 25, 2025
The significance of tumor microenvironment for immunotherapy in melanoma and non-melanoma skin cancerTaku Fujimura
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 17, 2023
[Ⅳ. Systemic Therapy for Angiosarcoma-Past, Present and Future]Taku Fujimura
International Journal of Molecular Sciences|April 12, 2022
Stromal Factors as a Target for Immunotherapy in Melanoma and Non-Melanoma Skin CancersTaku Fujimura
Biomedical Journal|March 20, 2025
Significance of PAI-1 on the development of skin cancer: optimal targets for cancer therapiesTaku Fujimura
Acta Dermato-Venereologica|August 18, 2016
Response to the Comment by Kan WuTaku Fujimura
Biomolecules|July 26, 2020
Significance of Immunosuppressive Cells as a Target for Immunotherapies in Melanoma and Non-Melanoma Skin CancersTaku Fujimura, Setsuya Aiba
Current Treatment Options in Oncology|September 26, 2025
PAI-1 in Skin Malignancies: a Central Regulator of Tumor Progression and Therapeutic ResistanceTaku Fujimura, Yoshihide Asano
European Journal of Dermatology : EJD|July 17, 2024
Multiple squamous cell carcinomas in situ in a patient with lung cancer treated with tepotinibToshiki Okazaki, Taku Fujimura, Yoshihide Asano
Oncoimmunology|December 18, 2012
Crosstalk between regulatory T cells (Tregs) and myeloid derived suppressor cells (MDSCs) during melanoma growthTaku Fujimura, Yumi Kambayashi, Setsuya Aiba
Acta Dermato-Venereologica|June 21, 2003
Disseminated papular interstitial elastolytic giant cell granulomaTaku Fujimura, Tadashi Terui, Hachiro Tagami
Pageof 29

Showing results (1-10 of 283) with videos related to

Sort By:
Pageof 29
Immunological Medicine|August 25, 2025
The significance of tumor microenvironment for immunotherapy in melanoma and non-melanoma skin cancerTaku Fujimura
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 17, 2023
[Ⅳ. Systemic Therapy for Angiosarcoma-Past, Present and Future]Taku Fujimura
International Journal of Molecular Sciences|April 12, 2022
Stromal Factors as a Target for Immunotherapy in Melanoma and Non-Melanoma Skin CancersTaku Fujimura
Biomedical Journal|March 20, 2025
Significance of PAI-1 on the development of skin cancer: optimal targets for cancer therapiesTaku Fujimura
Acta Dermato-Venereologica|August 18, 2016
Response to the Comment by Kan WuTaku Fujimura
Biomolecules|July 26, 2020
Significance of Immunosuppressive Cells as a Target for Immunotherapies in Melanoma and Non-Melanoma Skin CancersTaku Fujimura, Setsuya Aiba
Current Treatment Options in Oncology|September 26, 2025
PAI-1 in Skin Malignancies: a Central Regulator of Tumor Progression and Therapeutic ResistanceTaku Fujimura, Yoshihide Asano
European Journal of Dermatology : EJD|July 17, 2024
Multiple squamous cell carcinomas in situ in a patient with lung cancer treated with tepotinibToshiki Okazaki, Taku Fujimura, Yoshihide Asano
Oncoimmunology|December 18, 2012
Crosstalk between regulatory T cells (Tregs) and myeloid derived suppressor cells (MDSCs) during melanoma growthTaku Fujimura, Yumi Kambayashi, Setsuya Aiba
Acta Dermato-Venereologica|June 21, 2003
Disseminated papular interstitial elastolytic giant cell granulomaTaku Fujimura, Tadashi Terui, Hachiro Tagami
Pageof 29